Association of breast cancer susceptibility variants with risk of pancreatic cancer
- PMID:19843670
- PMCID: PMC3248348
- DOI: 10.1158/1055-9965.EPI-09-0306
Association of breast cancer susceptibility variants with risk of pancreatic cancer
Abstract
Background: A number of susceptibility genes are common to breast and pancreatic cancer. Recently, several breast cancer susceptibility loci have been identified through genome-wide association studies. Here we evaluated possible associations between these single nucleotide polymorphisms (SNP) and pancreatic cancer risk.
Methods: Ten SNPs from FGFR2, TOX3, MAP3K1, H19, LSP1, chromosome 8q24, CASP8, and LUM were investigated for associations with pancreatic cancer risk following genotyping in 1,143 Caucasian individuals with pancreatic adenocarcinoma and 1,097 unaffected controls from a clinic-based pancreatic cancer case-control study.
Results: CASP8 rs1045485 [odds ratio (OR), 0.78; 95% confidence interval (95% CI), 0.65-0.9; P = 0.005] and MAP3K1 rs889312 (OR, 0.85; 95% CI, 0.74-0.97; P = 0.017) showed evidence of association with risk of pancreatic cancer. The CASP8 rs1045485 association was evident in ever smokers (P = 0.002), but not in nonsmokers (P = 0.55), and the effect was strongest in heavy smokers (OR, 0.52; 95% CI, 0.29-0.93; P = 0.03). In contrast the MAP3K1 rs889312 association was only evident in nonsmokers (OR, 0.78; 95% CI, 0.64-0.95; P = 0.01). In addition, evaluation of the influence of the 10 SNPs on survival detected significant associations between outcome for locally advanced pancreatic cancer cases and both 8q rs6983561 (P = 0.045) and LUM rs2268578 (P = 0.02).
Conclusion: Association studies in a large pancreatic case-control study indicate that SNPs associated with breast cancer may also be associated with pancreatic cancer susceptibility and survival.
Conflict of interest statement
Similar articles
- Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, Berg CD, Buring JE, Chanock SJ, Diver WR, Dostal L, Fournier A, Hankinson SE, Henderson BE, Hoover RN, Isaacs C, Johansson M, Kolonel LN, Kraft P, Lee IM, McCarty CA, Overvad K, Panico S, Peeters PH, Riboli E, Sanchez MJ, Schumacher FR, Skeie G, Stram DO, Thun MJ, Trichopoulos D, Zhang S, Ziegler RG, Hunter DJ, Lindström S, Canzian F.Campa D, et al.J Natl Cancer Inst. 2011 Aug 17;103(16):1252-63. doi: 10.1093/jnci/djr265. Epub 2011 Jul 26.J Natl Cancer Inst. 2011.PMID:21791674Free PMC article.
- Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.Özgöz A, İçduygu FM, Yükseltürk A, ŞamlI H, Öztürk KH, Başkan Z.Özgöz A, et al.J Genet. 2020;99:15.J Genet. 2020.PMID:32366738
- Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.Kuo SH, Yang SY, You SL, Lien HC, Lin CH, Lin PH, Huang CS.Kuo SH, et al.Oncotarget. 2017 Mar 28;8(13):20925-20938. doi: 10.18632/oncotarget.14995.Oncotarget. 2017.PMID:28178648Free PMC article.
- Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.Peng S, Lü B, Ruan W, Zhu Y, Sheng H, Lai M.Peng S, et al.Breast Cancer Res Treat. 2011 Jun;127(2):309-24. doi: 10.1007/s10549-011-1459-5. Epub 2011 Mar 29.Breast Cancer Res Treat. 2011.PMID:21445572Review.
- Breast cancer genome-wide association studies: there is strength in numbers.Fanale D, Amodeo V, Corsini LR, Rizzo S, Bazan V, Russo A.Fanale D, et al.Oncogene. 2012 Apr 26;31(17):2121-8. doi: 10.1038/onc.2011.408. Epub 2011 Sep 26.Oncogene. 2012.PMID:21996731Review.
Cited by
- Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China.Zhao XK, Mao YM, Meng H, Song X, Hu SJ, Lv S, Cheng R, Zhang TJ, Han XN, Ren JL, Qi YJ, Wang LD.Zhao XK, et al.PLoS One. 2017 May 18;12(5):e0177504. doi: 10.1371/journal.pone.0177504. eCollection 2017.PLoS One. 2017.PMID:28542283Free PMC article.
- Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation.Zhang H, Wang Y, Liu Z, Yao B, Dou C, Xu M, Li Q, Jia Y, Wu S, Tu K, Liu Q.Zhang H, et al.FEBS Open Bio. 2016 Nov 7;6(12):1227-1237. doi: 10.1002/2211-5463.12139. eCollection 2016 Dec.FEBS Open Bio. 2016.Retraction in:FEBS Open Bio. 2022 Dec;12(12):2255. doi: 10.1002/2211-5463.13509.PMID:28255535Free PMC article.Retracted.
- Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.Lavender NA, Rogers EN, Yeyeodu S, Rudd J, Hu T, Zhang J, Brock GN, Kimbro KS, Moore JH, Hein DW, Kidd LC.Lavender NA, et al.BMC Med Genomics. 2012 Apr 30;5:11. doi: 10.1186/1755-8794-5-11.BMC Med Genomics. 2012.PMID:22546513Free PMC article.
- Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies.Abnet CC, Wang Z, Song X, Hu N, Zhou FY, Freedman ND, Li XM, Yu K, Shu XO, Yuan JM, Zheng W, Dawsey SM, Liao LM, Lee MP, Ding T, Qiao YL, Gao YT, Koh WP, Xiang YB, Tang ZZ, Fan JH, Chung CC, Wang C, Wheeler W, Yeager M, Yuenger J, Hutchinson A, Jacobs KB, Giffen CA, Burdett L, Fraumeni JF Jr, Tucker MA, Chow WH, Zhao XK, Li JM, Li AL, Sun LD, Wei W, Li JL, Zhang P, Li HL, Cui WY, Wang WP, Liu ZC, Yang X, Fu WJ, Cui JL, Lin HL, Zhu WL, Liu M, Chen X, Chen J, Guo L, Han JJ, Zhou SL, Huang J, Wu Y, Yuan C, Huang J, Ji AF, Kul JW, Fan ZM, Wang JP, Zhang DY, Zhang LQ, Zhang W, Chen YF, Ren JL, Li XM, Dong JC, Xing GL, Guo ZG, Yang JX, Mao YM, Yuan Y, Guo ET, Zhang W, Hou ZC, Liu J, Li Y, Tang S, Chang J, Peng XQ, Han M, Yin WL, Liu YL, Hu YL, Liu Y, Yang LQ, Zhu FG, Yang XF, Feng XS, Wang Z, Li Y, Gao SG, Liu HL, Yuan L, Jin Y, Zhang YR, Sheyhidin I, Li F, Chen BP, Ren SW, Liu B, Li D, Zhang GF, Yue WB, Feng CW, Qige Q, Zhao JT, Yang WJ, Lei GY, Chen LQ, Li EM, Xu LY, Wu ZY, Bao ZQ, Chen JL, Li XC, Zhuang X, Zhou YF, Zuo XB, Dong ZM, Wang LW, Fan XP, Wang J, Zhou Q, Ma GS, Zhang QX, Liu H, Jian XY, Lian SY, Wang JS, Chang FB, Lu CD, Miao JJ, Chen ZG, Wang R, Guo M, Fan ZL, Tao P, Liu T…See abstract for full author list ➔Abnet CC, et al.Hum Mol Genet. 2012 May 1;21(9):2132-41. doi: 10.1093/hmg/dds029. Epub 2012 Feb 8.Hum Mol Genet. 2012.PMID:22323360Free PMC article.
- Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry.Wang S, Zheng Y, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Huo D.Wang S, et al.Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):116-118. doi: 10.1158/1055-9965.EPI-17-0755. Epub 2017 Dec 18.Cancer Epidemiol Biomarkers Prev. 2018.PMID:29254938Free PMC article.
References
- Lynch HT, Fusaro L, Lynch JF. Familial pancreatic cancer: a family study. Pancreas. 1992;7:511–5. - PubMed
- Schenk M, Schwartz AG, O'Neal E, et al. Familial risk of pancreatic cancer. J Natl Cancer Inst. 2001;93:640–4. - PubMed
- Petersen GM, Hruban RH. Familial pancreatic cancer: where are we in 2003? J Natl Cancer Inst. 2003;95:180–1. - PubMed
- Goldstein AM, Fraser MC, Struewing JP, et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med. 1995;333:970–4. - PubMed
- Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000;119:1447–53. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous